The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care

Peer Review reports

Original Submission
1 May 2023	Submitted	Original manuscript
3 May 2023	Reviewed	Reviewer Report - Kirsty Loudon
4 May 2023	Author responded	Author comments - Sibel Saya
Resubmission - Version 2
4 May 2023	Submitted	Manuscript version 2
Publishing
6 May 2023	Editorially accepted
19 May 2023	Article published	10.1186/s13063-023-07361-6

Back to article page